Form 4 Tracker
Jazz Pharmaceuticals plc
JAZZ

11 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 15, 2026Jun 17 4:45 PMMark Douglas SmithDirector
Sale
1,157$230.55$266.7K9,680(D)

View →

Jun 10, 2026Jun 12 4:14 PMNeena M PatilEVP & Chief Legal Officer
Sale
1,200$231.83$278.2K51,549(D)

View →

Jun 1, 2026Jun 3 5:09 PMBruce C CozaddDirector
Sale
6,000$235.12$1.4M372,682(D)

View →

May 28, 2026Jun 1 4:09 PMNeena M PatilEVP & Chief Legal Officer
Sale
1,192$236.97$282.5K52,626(D)

View →

May 28, 2026Jun 1 4:06 PMSamantha PearceEVP, Chief Commercial Officer
Sale
6,907$235.41$1.6M50,272(D)

View →

May 22, 2026May 27 6:13 PMRick E WinninghamDirector
Sale
2,741$241.57$662.1K9,567(D)

View →

May 22, 2026May 27 6:07 PMHeather Ann McsharryDirector
Sale
2,000$241.00$482.0K18,449(D)

View →

May 1, 2026May 5 4:27 PMBruce C CozaddDirector
Sale
6,000$203.33$1.2M378,682(D)

View →

Apr 1, 2026Apr 3 5:09 PMBruce C CozaddDirector
Sale
6,000$190.50$1.1M384,682(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 28, 2026Jun 1 4:06 PMSamantha PearceEVP, Chief Commercial Officer
Option Exercise
6,907$109.450(D)

View →

May 28, 2026Jun 1 4:01 PMSeamus MulliganDirector
Option Exercise
3,415$138.080(D)

View →

May 22, 2026May 27 6:13 PMRick E WinninghamDirector
Option Exercise
3,415$138.080(D)

View →